Tefferi A
Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
Int J Hematol. 2001 Feb;73(2):170-6. doi: 10.1007/BF02981934.
Chronic myeloproliferative disorders are operationally classified to include essential thrombocythemia, polycythemia vera, and agnogenic myeloid metaplasia. In most cases, clonal hematopoiesis, involving all 3 myeloid lineages, can be demonstrated. However, the underlying molecular lesions that are responsible for disease initiation and progression remain elusive. There are ongoing efforts to clarify the pathogenetic role of cytokines, bone marrow stromal cells and molecules, and intracellular aberrations in either signal transduction or apoptosis. This review discusses some of the current and past observations regarding the pathogenesis of chronic myeloproliferative disorders.
慢性骨髓增殖性疾病在临床上分为原发性血小板增多症、真性红细胞增多症和特发性骨髓化生。在大多数情况下,可证实存在涉及所有3个髓系谱系的克隆性造血。然而,导致疾病发生和进展的潜在分子病变仍不清楚。目前正在努力阐明细胞因子、骨髓基质细胞和分子以及信号转导或细胞凋亡中的细胞内异常的致病作用。这篇综述讨论了一些关于慢性骨髓增殖性疾病发病机制的当前和过去的观察结果。